LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $33.6 million.
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Aktis Oncology (AKTS) at Outperform
- Ormat Technologies (ORA) PT Raised to $145 at Oppenheimer
- Needham Reiterates Buy Rating on ServiceTitan (TTAN)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
